ONCOLOGY RESEARCH INFORMATION EXCHANGE NETWORK
LIVE

Serial Number

86271626

Owner

Moffitt Genetics Corporation

Attorney

Karen K. Won

Filing Date

May 5, 2014

Add to watchlist:

No watchlists yet
View on USPTO

ONCOLOGY RESEARCH INFORMATION EXCHANGE NETWORK Trademark

Serial Number: 86271626 • Registration: 4966469

ONCOLOGY RESEARCH INFORMATION EXCHANGE NETWORK is a trademark filed by Moffitt Genetics Corporation on May 5, 2014. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently registered and active.

Owner Contact Info

Moffitt Genetics Corporation (5 trademarks)

10902 N. McKinley Drive
Tampa, FL 33612

Entity Type: 03

M2GEN, CORP. (9 trademarks)

TAMPA, FL 33612

Entity Type: 03

Trademark Details

Filing Date

May 5, 2014

Registration Date

May 24, 2016

Goods & Services

Data collection for research purposes, namely, providing medical evaluations of patients to determine acceptability for participation in clinical trials; Providing healthcare counseling, screening, diagnosis, prognosis, treatment, relapse, palliative, integrative medicine, survivorship, and other related medical information in the field of cancer; Healthcare services, namely, providing a database in the field of oncology and featuring inputting and collection of data and information all for treatment and diagnosis purposes; healthcare consultation in the field of cancer treatment research, namely, advising patients on cancer treatment research studies in which they might participate for purposes of treating their conditions

Medical, clinical, and scientific research in the field of cancer; Application service provider (ASP) featuring software for medical affair management and information exchange; providing a website featuring non-downloadable software for medical affair management and information exchange; providing an on-line computer database featuring medical and scientific research information in the field of cancer and immunological disorders that allows for input and collection of scientific and research data and information; Scientific and technological services, namely, collaborative scientific research and development services for researchers in the fields of oncology, namely, development of proprietary bioinformatic analysis software pipelines and computer systems for collecting, storing, characterizing, sorting, viewing, and delivering medical data and research information to clients; designing genomic experiments in context of client driven strategic goals; providing scientific research data, including custom, proprietary bioinformatic analysis of data generated in the fields of genomics and oncology; data collection for research purposes, namely, data mining and pattern recognition, designing clinical studies, and generating genomic data from patient samples; Data collection for research purposes, namely, the collection and systematic sorting of clinical and patient data comprising patient specific clinical data and scientific clinical studies; data collection for research purposes, namely, the collection of mathematical and statistical data, clinical data, patient data and data of clinical studies relating to clinical response to cancer treatments; compiling data for research purposes in the field of medical science, namely, compiling patient specific molecular and genomic data, patient specific clinical data and scientific clinical studies; scientific and technological services, namely, research services for medical purposes in the field of medical diagnostic and treatment research; providing medical and scientific research information and scientific consulting in the fields of oncology; providing an online database comprised of medical, pharmaceutical, biological and genomic information for scientific research purposes; providing an online searchable database in the fields of biological medical, translational medicine, interventional epidemiology, bioinformatics, clinical information technology, genomic data and genomic sequence analysis for scientific research purposes; design and development of computer software in the fields of bioinformatics and oncology; design and development of computer software for integration of patient specific data, molecular test results, clinical studies and scientific results; providing online nondownloadable medical diagnostic and treatment research computer software for use by healthcare professionals; providing an online searchable database for clinical and scientific research in the field of oncology; Software as a Service (SAAS) services featuring software for providing information for patient treatment by enabling the retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical purposes; providing online non-downloadable software for retrieval and correlation of genomic data, drug protocols, clinical profiling and integration and statistical analysis of data for medical diagnostic and treatment research purposes; medical research and scientific research and scientific consulting services, namely, designing and conducting clinical studies and selecting patients for clinical studies in the field of cancer therapy for others; Conducting clinical trial matching between patients with cancer and organizations conducting or administering clinical trials in the nature of medical research; technological and scientific data analysis in the field of oncology; scientific and research consulting services, namely, technical data collection, research analysis and technical reporting of patients' outcomes and resulting prescribing data related thereto in the field of oncology; providing temporary use of non-downloadable scientific research and analysis software in the field of oncology and bioinformatics; Providing a website portal featuring bioinformatic research data and search engine for biomedical data for data mining and pattern recognition, selecting patients for clinical studies, designing clinical studies, and generating genomic data from patient samples in the field of oncology; providing temporary use of non-downloadable bioinformatic software for diagnosing medical conditions, preparing medical data, research and reports for data mining and pattern recognition, selecting patient for clinical studies, designing clinical studies, and generating genomic data from patient samples in the field of oncology; technical and scientific data analysis in the field of oncology

Publications, namely, printed materials, brochures, pamphlets, bulletins, newsletter and magazines in the field of cancer, bioinformatics and biotechnologies

Medical educational and training services, namely, conducting lectures, seminars, workshops, conferences, internships, fellowships, residencies, and workshops in the field of cancer

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Dec 11, 2025 NA89
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Dec 11, 2025 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Dec 11, 2025 89AG
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 11, 2025 APRE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 11, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 11, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 11, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 11, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 11, 2025 COAR
TEAS SECTION 8 & 9 RECEIVED
Aug 29, 2025 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
May 24, 2025 REM2
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Nov 10, 2022 NAS8
REGISTERED - SEC. 8 (6-YR) ACCEPTED
Nov 10, 2022 8.OK
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
Nov 8, 2022 EROP
OFFICE ACTION ISSUED POU1
May 25, 2022 PUM1
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
May 25, 2022 APRE
TEAS SECTION 8 RECEIVED
May 10, 2022 ES8R
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
May 24, 2021 REM1
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Aug 29, 2018 ASGN
REGISTERED-SUPPLEMENTAL REGISTER
May 24, 2016 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 15, 2016 PREV
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Apr 8, 2016 CNTA
EXAMINER'S AMENDMENT ENTERED
Apr 8, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 8, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 8, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 8, 2016 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 29, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 29, 2016 CRFA
ASSIGNED TO LIE
Mar 18, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 5, 2016 TROA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Sep 16, 2015 AAUA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 15, 2015 GNRN
NON-FINAL ACTION E-MAILED
Sep 15, 2015 GNRT
NON-FINAL ACTION WRITTEN
Sep 15, 2015 CNRT
USE AMENDMENT ACCEPTED
Sep 15, 2015 IUAA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 11, 2015 TEME
AMENDMENT TO USE PROCESSING COMPLETE
Sep 11, 2015 AUPC
USE AMENDMENT FILED
Sep 11, 2015 IUAF
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 10, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 10, 2015 TROA
TEAS AMENDMENT OF USE RECEIVED
Sep 10, 2015 EAAU
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 11, 2015 GNRN
NON-FINAL ACTION E-MAILED
Mar 11, 2015 GNRT
NON-FINAL ACTION WRITTEN
Mar 11, 2015 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 11, 2015 GNRN
NON-FINAL ACTION E-MAILED
Mar 11, 2015 GNRT
NON-FINAL ACTION WRITTEN
Mar 11, 2015 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2015 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 22, 2015 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 22, 2015 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 21, 2014 GNRN
NON-FINAL ACTION E-MAILED
Aug 21, 2014 GNRT
NON-FINAL ACTION WRITTEN
Aug 21, 2014 CNRT
ASSIGNED TO EXAMINER
Aug 19, 2014 DOCK
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 5, 2014 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 5, 2014 COAR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 16, 2014 NWOS
NEW APPLICATION ENTERED
May 8, 2014 NWAP